Asymptomatic Severe Aortic Stenosis in the Elderly: When to Intervene

Asymptomatic Severe Aortic Stenosis in the Elderly: When to InterveneThis work studies the natural history of aortic stenosis and the optimal timing to intervene elderly patients with asymptomatic severe aortic stenosis.

 

This disease is increasingly misdiagnosed in the elderly population, and this goes hand in hand with enhanced therapeutic options.

 

Prior studies on the natural history of this disease were made on much younger populations (between 60 and 70) and it was these studies clinical guidelines were based on.

 

Deciding when to intervene elderly patients based on guidelines written for younger patients, could lead to serious mistakes. This is the first work to study the natural history of aortic stenosis in elderly patients. 

 

A total of 103 consecutive >70 patients (mean age 77±5 years) with asymptomatic severe aortic stenosis (peak systolic velocity 4.7±0.6 m/s) were followed up prospectively.

 

During follow up, there were 91 events, including aortic valve replacement indication in 82 patients, and cardiac death in 9 patients. Event free survival rate was:

  • 73% at one year
  • 43% at two years
  • 23% at three years
  • 16% at four years

 

Symptoms onset was severe (functional class ≥3) in 43% of the population.

 

Patients with peak systolic velocity ≥5 m/s presented:

  • 21% event free survival rate at two years
  • 4% event free survival rate at four years.

 

Patients with peak systolic velocity <5 m/s (p<0.001) presented:

  • 57% event free survival rate at two years
  • 23% event free survival rate at four years

 

Seventy one patients received aortic valve replacement and postop survival rate was 89% at one year and 77% at 3 years after procedure.

 

Conclusion

It might be difficult to detect mild symptoms in elderly patients with asymptomatic severe aortic stenosis, even when closely monitored.  We should expect a high events rate, and cardiac death at symptom onset is not infrequent.

[plain]

 

Because of this, elective aortic valve replacement should be considered particularly in patients with more than 5 m/s peak velocity and relatively low periprocedural risk.

[/plain]

 

Original Title: Asymptomatic Severe Aortic Stenosis in the Elderly.

Reference: Robert Zilberszac et al. J Am Coll Cardiol Img 2017;10:43–50.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Percutaneous Tricuspid Valve Replacement with Lux-Valve

Tricuspid regurgitation (TR) is a condition associated with poor quality of life, frequent hospitalizations due to heart failure, and increased mortality, even under optimal...

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...